Loyal, a biotech company, is conducting clinical trials in Colorado for a new drug that aims to increase canine lifespan. The FDA has approved the trial, and the next stage involves demonstrating the drug's effectiveness through rigorous testing.
Clinical trials are underway in Colorado for a new drug that could extend a dog’s lifespan. Loyal, a San Francisco-based biotech company, is developing the drug and seeking FDA approval.The U.S. Food and Drug Administration determined that Loyal’s drug has a “reasonable expectation of effectiveness.” The next step is for the company to show that its drug actually extends lifespan through the clinical trials. Each dog takes one pill a day, which targets metabolic dysfunction in the pet.
The trials are double-blind, meaning half of the dogs receive the drug, while the other half get a placebo. Neither the veterinarian or the dog’s owner know which drug the dog received
DRUG TRIAL LIFESPAN EXTENSION CANINE HEALTH CLINICAL TRIALS BIOTECH
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mike Madigan trial live updates: Former state Rep. Acevedo to testify in ex-speaker trialTrial expected to last months
Read more »
Viridian Shares Soar After Latest Trial Success for Thyroid Eye Disease DrugViridian Therapeutics' experimental treatment for chronic thyroid eye disease (TED) significantly reduced symptoms such as double vision and eye bulging in a late-stage...
Read more »
Novo Nordisk shares plunge 24% after CagriSema obesity drug trial resultsShares of Danish pharmaceutical giant Novo Nordisk plummeted more than 24% at one point on Friday after reporting trial results that missed expectations.
Read more »
Novo Nordisk shares plummet after weight-loss drug's disappointing trial resultsNew weight loss drug could be a ‘better Ozempic’
Read more »
Argentina Court Orders Two Men to Pre-Trial Detention in Liam Payne Drug CaseAn Argentine court has ordered two men to be held in pre-trial detention in connection with the death of former One Direction singer Liam Payne. Payne was found dead in October after falling from the balcony of his hotel room in Buenos Aires. The court ruled that the two men, one a hotel employee and the other a waiter Payne met at a restaurant, supplied him with drugs.
Read more »
Prosecutors Seek to Use Prior Convictions in Drug Trafficking TrialFederal prosecutors are seeking to introduce prior criminal convictions at the upcoming trial of Glennie Antonio McGee and several co-defendants. They argue that these convictions, which include charges related to drugs and firearms, are relevant to demonstrating motive, opportunity, and planning in the current allegations of a sophisticated drug distribution network.
Read more »